Eloxx warned by Nasdaq: MVLS below $35M, faces potential delisting

Eloxx Pharmaceuticals, Inc.

Received Nasdaq notice on Oct 11, 2022; MVLS below $35M minimum for 30 consecutive business days.
No immediate effect on listing; common stock continues trading on Nasdaq Capital Market under symbol ELOX.
180-day compliance period until April 10, 2023 to regain compliance by closing MVLS at $35M+ for 10 consecutive days.
If compliance not regained, Nasdaq will provide delisting notification; Company may appeal to hearings panel.
Company intends to monitor MVLS and evaluate options but cannot assure regaining compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.